RT SocSurgOnc RT AnnSurgOncol: JULY ISSUE:Postoperative Adjuvant #Trans-ArterialChemoembolization for Patients with #HepatocellularCarcinoma and Portal Vein Tumor Thrombus. https://t.co/fYYdoMszbW McMastersKelly SocSurgOnc https://t.co/oqErjsbTjA
RT @AnnSurgOncol: JULY ISSUE:Postoperative Adjuvant #Trans-ArterialChemoembolization for Patients with #HepatocellularCarcinoma and Portal…
RT @AnnSurgOncol: JULY ISSUE:Postoperative Adjuvant #Trans-ArterialChemoembolization for Patients with #HepatocellularCarcinoma and Portal…
RT @AnnSurgOncol: JULY ISSUE:Postoperative Adjuvant #Trans-ArterialChemoembolization for Patients with #HepatocellularCarcinoma and Portal…
RT @AnnSurgOncol: JULY ISSUE:Postoperative Adjuvant #Trans-ArterialChemoembolization for Patients with #HepatocellularCarcinoma and Portal…
RT @AnnSurgOncol: JULY ISSUE:Postoperative Adjuvant #Trans-ArterialChemoembolization for Patients with #HepatocellularCarcinoma and Portal…
JULY ISSUE:Postoperative Adjuvant #Trans-ArterialChemoembolization for Patients with #HepatocellularCarcinoma and Portal Vein Tumor Thrombus. https://t.co/WgKE6LN9hU @McMastersKelly @SocSurgOnc https://t.co/zqEltjt9DO